Using the latest gene sequencing tools to examine so-called epigenetic influences on the DNA makeup of colon cancer, a Johns Hopkins team says its results suggest cancer treatment might eventually be more tolerable and successful if therapies could focus on helping cancer cells get back to normal in addition to strategies for killing them.
Mettler Toledo introduces the Good Titration Practice Risk Checker, an on-line tool that allows labs to quickly assess their titration risk and the reliability of their results.
Avid Nano's BladeCell disposable cuvette improves Dynamic Light Scattering sample preparation time by a factor of eight compared to using traditional quartz cuvettes.
Wyatt Technology Corporation announces that its multi-angle light scattering instruments represent the latest European Pharmacopoeia requirements for hydroxyethyl starch characterization.
The pharmaceutical industry spent less on drug R&D last year than at any time in the last three years, according to data released from the 2011 Pharmaceutical R&D Factbook complied by CMR International.
EnVivo Pharmaceuticals announced that it recently initiated a Phase 1 clinical trial of EVP-0962, its potent and selective gamma secretase modulator, in healthy volunteers.
Australian monoclonal antibody company, Immune System Therapeutics Limited, announced that its antibody treatment for terminal blood cancer had received Orphan Drug Designation from US health regulators.
U.S. Food and Drug Administration officials say doctors should use lower doses of anemia drugs when treating patients with failing kidneys due to the increased risk of stroke, blood clots and death.
Drugmaker Pfizer Inc. said in a regulatory finding it is studying the possibility of entering a "strategic transaction" with the biopharmaceutical company Icagen Inc. that could result Icagen being acquired.
Bristol-Myers Squibb Co. and AstraZeneca PLC said that dapagliflozin, a potential new drug for Type 2 diabetes patients, holds promise after a late-stage clinical study.
Tecan has updated its Infinite M1000, a multimode microplate reader with new features.
Krystal Glass Bottom Plates from Porvair Sciences provide performance for whole-plate CCD imaging and laser detection applications.
Agilent Automation Solutions’ “Reference Guide to Optimal Microplate Sealing” was written for laboratories looking to optimize microplate sealing processes to safeguard the integrity of their samples.
Researchers from the Universities of Leeds and Illinois, and Columbia University, studied a particular type of cryoprotectants known as osmolytes. They found that small osmolyte molecules are better at protecting proteins than larger ones.
Irish drugmaker Shire Plc said on June 24 the European Medicines Agency has approved a new manufacturing site in Massachusetts that will be used to make the Fabry disease treatment, Replagal.